CAS 144625-51-4: [1-[2-[(Methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl 1-methyl-1H-indole-3-carboxylate
Formula:C19H27N3O4S
InChI:InChI=1S/C19H27N3O4S/c1-21-13-17(16-5-3-4-6-18(16)21)19(23)26-14-15-7-10-22(11-8-15)12-9-20-27(2,24)25/h3-6,13,15,20H,7-12,14H2,1-2H3
InChI key:InChIKey=MOZPSIXKYJUTKI-UHFFFAOYSA-N
SMILES:O=C(OCC1CCN(CCNS(=O)(=O)C)CC1)C2=CN(C=3C=CC=CC23)C
- Synonyms:
- 1-methyl-1H-Indole-3-carboxylic acid [1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl ester
- 1H-Indole-3-carboxylic acid, 1-methyl-, [1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl ester
- Gr 113808
- Gr113808
- [1-[2-[(Methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl 1-methyl-1H-indole-3-carboxylate
- (1-{2-[(Methylsulfonyl)amino]ethyl}piperidin-4-yl)methyl 1-methyl-1H-indole-3-carboxylate
![discount label](https://static.cymitquimica.com/public/img/discount.png)
1H-Indole-3-carboxylic acid, 1-methyl-, [1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl ester
CAS:144625-51-4
Formula:
C19H27N3O4S
Purity:
95%
Color and Shape:
Solid
Molecular weight:
393.5004
Ref: IN-DA001JVQ
1mg | 103.00 € | ||
5mg | 274.00 € | ||
10mg | 601.00 € | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
GR 113808
Controlled ProductCAS:144625-51-4
GR 113808 is a potent, reversible, and selective 5-HT4 receptor antagonist that blocks the binding …
Formula:
C19H27N3O4S
Purity:
Min. 95%
Molecular weight:
393.5 g/mol
Ref: 3D-UFA62551
25mg | 796.00 € | ||
50mg | 1,198.00 € | ||
100mg | 1,667.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
GR 113808
CAS:144625-51-4
GR 113808 is a 5-HT4 receptor antagonist that inhibits 5-HT1B and 5-HT3 receptors and attenuates …
Formula:
C19H27N3O4S
Purity:
98.16%
Color and Shape:
Solid
Molecular weight:
393.5
Ref: TM-T15414
1mg | 38.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025